A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
This study is currently recruiting participants.
Study NCT00569140.
Last updated on January 9, 2009.
Information provided by Ophthotech Corporation
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
